CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH)
Clinical trials for CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) trials appear
Sign up with your email to follow new studies for CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which drug is best for pulmonary hypertensive crisis? new trial aims to find out
Disease control Not yet recruitingThis trial will compare three drugs—dopamine, norepinephrine, and epinephrine—to see which works best for people experiencing a pulmonary hypertensive crisis, a life-threatening spike in blood pressure in the lungs. The study will enroll 75 adults with pulmonary arterial hyperten…
Matched conditions: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH)
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Toxins in hair and urine: could they trigger rare lung disease?
Knowledge-focused Not yet recruitingThis study looks at whether environmental toxins, drugs, and workplace exposures play a role in causing pulmonary arterial hypertension (PAH), a rare and serious lung condition. Researchers will compare 150 newly diagnosed patients with PAH to those with another form of pulmonary…
Matched conditions: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH)
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC